Alfred J Novak's most recent trade in Pasithea Therapeutics Corp was a trade of 2,750 Common Stock done at an average price of $5.6 . Disclosure was reported to the exchange on June 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pasithea Therapeutics Corp | Alfred J Novak | Director | Grant, award, or other acquisition of securities at price $ 5.62 per share. | 12 Jun 2024 | 2,750 | 3,500 | - | 5.6 | 15,455 | Common Stock |
| Pasithea Therapeutics Corp | Alfred J Novak | Director | Grant, award, or other acquisition of securities at price $ 5.61 per share. | 12 Jun 2024 | 750 | 750 | - | 5.6 | 4,208 | Common Stock |
| Pasithea Therapeutics Corp | Alfred J Novak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Pasithea Therapeutics Corp | Alfred J Novak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Pasithea Therapeutics Corp | Alfred J Novak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2022 | 100,000 | 100,000 | - | - | Stock Option (to acquire Common Stock) | |
| LivaNova PLC | Alfred J Novak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 1,346 | 0 | - | - | Restricted Stock Units | |
| LivaNova PLC | Alfred J Novak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 1,346 | 12,714 (0%) | 0% | 0 | Ordinary Shares | |
| LivaNova PLC | Alfred J Novak | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.94 per share. | 15 Jun 2022 | 97 | 12,617 (0%) | 0% | 59.9 | 5,814 | Ordinary Shares |
| LivaNova PLC | Alfred J Novak | Director | Sale of securities on an exchange or to another person at price $ 89.17 per share. | 10 Nov 2021 | 2,337 | 11,368 (0%) | 0% | 89.2 | 208,397 | Ordinary Shares |
| LivaNova PLC | Alfred J Novak | Director | Sale of securities on an exchange or to another person at price $ 90.77 per share. | 10 Nov 2021 | 644 | 13,705 (0%) | 0% | 90.8 | 58,453 | Ordinary Shares |
| LivaNova PLC | Alfred J Novak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2021 | 2,337 | 0 | - | - | Restricted Stock Units | |
| LivaNova PLC | Alfred J Novak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2021 | 2,337 | 14,349 (0%) | 0% | 0 | Ordinary Shares | |
| LivaNova PLC | Alfred J Novak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 1,346 | 1,346 | - | - | Restricted Stock Units |